switching between glp-1 agonists Mechanisms by which may exert beneficial effects on the Capsule 61 - Therapeutic Interchange:

Multiple Genes of the Renin-Angiotensin System Are Novel Targets of Wnt/-Catenin Signaling

In patients with cardiovascular diseases, clinical observations have demonstrated enhanced benefits of GLP-1RAs in treating prostate cancer

Some GLP-1RAs devices have the ability to easily adjust the dose in response to intolerance (e.g

This degradation is catalyzed by the ubiquitous serum enzyme dipeptidyl peptidase 4 (DPP-4), which is produced both locally in the intestine and by circulating white blood cells

Glucagon-like peptide 1 treatment reverses vascular remodelling by downregulating matrix metalloproteinase 1 expression through inhibition of the ERK1/2/NF-B signalling pathway

Increased FFA in the liver results in insulin resistance, hepatic glucose production, and pancreatic beta cell dysfunction [7]